Your browser doesn't support javascript.
loading
Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.
Zuo, Bingfeng; Zhang, Yang; Zhao, Kangjie; Wu, Li; Qi, Han; Yang, Rong; Gao, Xianjun; Geng, Mengyuan; Wu, Yingjie; Jing, Renwei; Zhou, Qibing; Seow, Yiqi; Yin, HaiFang.
Afiliação
  • Zuo B; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Zhang Y; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Zhao K; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Wu L; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Qi H; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Yang R; Department of Nanomedicine and Biopharmaceuticals, National Engineering Research Center for Nanomedicine, Huazhong University of Science and Technology, Wuhan, 430074, Hubei Province, China.
  • Gao X; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Geng M; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Wu Y; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Jing R; The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping
  • Zhou Q; Department of Nanomedicine and Biopharmaceuticals, National Engineering Research Center for Nanomedicine, Huazhong University of Science and Technology, Wuhan, 430074, Hubei Province, China.
  • Seow Y; Institute of Bioengineering and Bioimaging, 31 Biopolis Way, Singapore, 138669, Singapore.
  • Yin H; Institute of Molecular and Cell Biology, 61 Biopolis Way, Singapore, 138668, Singapore.
J Hematol Oncol ; 15(1): 46, 2022 04 29.
Article em En | MEDLINE | ID: mdl-35488312
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Vacinas Anticâncer / Exossomos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Vacinas Anticâncer / Exossomos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article